| Unjha Formulations Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531762 |
NSE Symbol : - |
P/E(TTM) : 29.52 |
|
ISIN Demat : INE576D01015 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.05 |
|
Book Value(₹) : 8.58 |
Market Cap(₹Cr) : 13.89 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 3.31 | 3.28 | 4.41 | 4.29 | 3.61 | 2.37 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 3.31 | 3.28 | 4.41 | 4.29 | 3.61 | 2.37 |
| Other Operating Income | 0.00 | 0.05 | 0.03 | 0.00 | 0.02 | 0.07 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 |
| Total Income | 3.31 | 3.33 | 4.44 | 4.35 | 3.63 | 2.44 |
| Total Expenditure | 3.11 | 3.78 | 4.16 | 3.50 | 3.21 | 2.70 |
| PBIDT | 0.20 | -0.45 | 0.28 | 0.85 | 0.42 | -0.26 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 0.19 | -0.45 | 0.28 | 0.85 | 0.42 | -0.26 |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 |
| Tax | 0.00 | 0.26 | 0.00 | 0.00 | 0.00 | 0.12 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.16 | -0.74 | 0.24 | 0.82 | 0.39 | -0.41 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.16 | -0.74 | 0.24 | 0.82 | 0.39 | -0.41 |
| EPS (Unit Curr.) | 0.35 | -1.66 | 0.53 | 1.83 | 0.87 | -0.91 |
| EPS (Adj) (Unit Curr.) | 0.35 | -1.66 | 0.53 | 1.83 | 0.87 | -0.91 |
| Calculated EPS (Unit Curr.) | 0.35 | -1.66 | 0.53 | 1.83 | 0.87 | -0.91 |
| Calculated EPS (Adj) (Unit Curr.) | 0.35 | -1.66 | 0.53 | 1.83 | 0.87 | -0.91 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.40 | -6.63 | 2.14 | 7.30 | 3.48 | -3.63 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.40 | -6.63 | 2.14 | 7.30 | 3.48 | -3.63 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 |
| Reserve & Surplus | 0.20 | 0.20 | 0.00 | 0.20 | 0.20 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 6.04 | -13.72 | 6.35 | 19.81 | 11.63 | -10.97 |
| PBDTM(%) | 5.74 | -13.72 | 6.35 | 19.81 | 11.63 | -10.97 |
| PATM(%) | 4.83 | -22.56 | 5.44 | 19.11 | 10.80 | -17.30 |
